Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A
Status:
Withdrawn
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the pharmacokinetic parameters of ReFacto and Advate,
using the chromogenetic substrate assay to measure plasma Factor VIII activity in plasma.